Wolverine Asset Management’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Wolverine Asset Management’s Portfolio LABD Stock Details LABD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-75	Closed	-$185K	–	1576
2019 Q4	$185K	Buy	75 +42	+127%	+$149K	﹤0.01%	985
2019 Q3	$167K	Hold	33	–	–	﹤0.01%	1034
2019 Q2	$118K	Hold	33	–	–	﹤0.01%	1104
2019 Q1	$121K	Buy	+33	New	+$160K	﹤0.01%	1102

Other funds holding LABD

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SFS

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wolverine Asset Management's LABD Position: Q1 2020 in Review

Wolverine Asset Management sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2020, closing a stake of 75 shares — an estimated $185K sold.

Wolverine Asset Management first reported a position in LABD in Q1 2019 and held it in 4 quarters. The position peaked at $185K in Q4 2019. 8 funds tracked by Wall St. Rank hold LABD as of Q1 2020.

Wolverine Asset Management reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2020 after selling out during the quarter.
Wolverine Asset Management sold 75 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2020, an estimated $185K.
Wolverine Asset Management first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2019 and held it in 4 quarters.
Wolverine Asset Management's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $185K in Q4 2019.
8 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2020.

Based on Wolverine Asset Management's 13F filing for Q1 2020, filed 13 May 2020.